The metabolic syndrome and cardiovas- cular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56:1113 1132. 652. Okamura T, Kokubo Y, Watanabe M, Higashiyama A, Ono Y, Nishimura K, Okayama A, Miyamoto Y. A revised definition of the metabolic syndrome predicts coronary artery disease and ischemic stroke after adjusting for low density lipoprotein cholesterol in a 13-year cohort study of Japanese: the Suita study. Atherosclerosis. 2011;217:201 206. 653. Yun JE, Won S, Sung J, Jee SH. Impact of metabolic syndrome indepen- dent of insulin resistance on the development of cardiovascular disease. Circ J. 2012;76:2443 2448. 654. Callahan A, Amarenco P, Goldstein LB, Sillesen H, Messig M, Samsa GP, Altafullah I, Ledbetter LY, MacLeod MJ, Scott R, Hennerici M, Zivin JA, Welch KM; SPARCL Investigators. Risk of stroke and car- diovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Arch Neurol. 2011;68:1245 1251. Meschia et al Guidelines for the Primary Prevention of Stroke 3825 655. Khang YH, Cho SI, Kim HR. Risks for cardiovascular disease, stroke, ischaemic heart disease, and diabetes mellitus associated with the meta- bolic syndrome using the new harmonised definition: findings from nationally representative longitudinal data from an Asian population. Atherosclerosis. 2010;213:579 585. 656. Cortez-Dias N, Martins S, Belo A, Fiuza M; Investigadores do estudo VALSIM. Comparison of definitions of metabolic syndrome in rela- tion to risk for coronary artery disease and stroke. Rev Port Cardiol. 2011;30:139 169. 657. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group. 